ArticleCancer diagnosis & prognosis

Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma.

Toru Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.